Clobetasol — Discount Pricing
Clobetasol is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Clobetasol Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $192.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Clobetasol
Clobetasol is a prescription medication. Ask your doctor if Clobetasol is right for you.
Other strengths and forms of Clobetasol
How to Check Clobetasol Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Clobetasol at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Dermatology
What Clobetasol is approved for (FDA label)
Clobetasol propionate topical spray, 0.05% is a corticosteroid indicated for the topical treatment of moderate to severe plaque psoriasis affecting up to 20% body surface area (BSA) in patients 18 years of age or older ( 1.1 ) Limitations of Use: Do not use on the face, axillae or groin.( 1.2 ) Do not use if atrophy is present at the treatment site.( 1.2 ) Do not use for rosacea or perioral dermatitis.( 1.2 ) 1.1 Indication Clobetasol propionate topical spray, 0.05% is a super-high potent topical corticosteroid formulation indicated for the treatment of moderate to severe plaque psoriasis affecting up to 20% body surface area (BSA) in patients 18 years of age or older.
Source: Read the full FDA label on DailyMed. Label effective date: July 17, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Dosage forms and strengths for Clobetasol (FDA label)
Spray, 0.05% w/w. Each gram of clobetasol propionate topical spray USP, 0.05% contains 0.5 mg of clobetasol propionate in a clear, colorless liquid. Spray, 0.05% w/w ( 3 )
Source: FDA prescribing information (DailyMed). Set ID: a83d212b-a970-4ee7-8431-fead6b2e7f9d. SPL document ID: 6c5ef90d-a66f-4b40-a813-ae836e38ac97. Label effective date: July 17, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Clobetasol (FDA label)
In controlled, clinical trials with clobetasol propionate topical spray, 0.05%, the most common adverse reactions (incidence > 2%) were burning, pruritus, nasopharyngitis, upper respiratory tract infection. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Alembic Pharmaceuticals, Inc. at 1-866-210-9797 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Source: FDA prescribing information (DailyMed). Set ID: a83d212b-a970-4ee7-8431-fead6b2e7f9d. SPL document ID: 6c5ef90d-a66f-4b40-a813-ae836e38ac97. Label effective date: July 17, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Clobetasol (FDA label)
None. None. ( 4 )
Source: FDA prescribing information (DailyMed). Set ID: a83d212b-a970-4ee7-8431-fead6b2e7f9d. SPL document ID: 6c5ef90d-a66f-4b40-a813-ae836e38ac97. Label effective date: July 17, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Warnings and precautions for Clobetasol (FDA label)
Clobetasol propionate is a highly potent topical corticosteroid that has been shown to suppress the HPA axis at the lowest doses tested. ( 5.1 ) Cushing's syndrome, hyperglycemia, and unmasking of latent diabetes mellitus can also result from systemic absorption of topical corticosteroids. ( 5.1 ) Systemic absorption may require periodic evaluation for HPA axis suppression. Modify use if HPA axis suppression develops. ( 5.1 ) Children may be more susceptible to systemic toxicity from use of topical corticosteroids. ( 5.1 , 8.4 ) Clobetasol propionate topical spray may increase the risk of cataract and glaucoma.
Source: FDA prescribing information (DailyMed). Set ID: a83d212b-a970-4ee7-8431-fead6b2e7f9d. SPL document ID: 6c5ef90d-a66f-4b40-a813-ae836e38ac97. Label effective date: July 17, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.